Difference between revisions of "About-cancer/treatment/drugs/leukemia"
(Marked this version for translation) |
|||
| Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
<translate> | <translate> | ||
| − | == Drugs Approved for Leukemia == | + | == Drugs Approved for Leukemia == <!--T:1--> |
| + | <!--T:2--> | ||
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for leukemia. The list includes generic and brand names. This page also lists common drug combinations used in leukemia. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used. | This page lists cancer drugs approved by the Food and Drug Administration (FDA) for leukemia. The list includes generic and brand names. This page also lists common drug combinations used in leukemia. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used. | ||
| + | <!--T:3--> | ||
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in leukemia that are not listed here. | The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in leukemia that are not listed here. | ||
| − | === Drugs Approved for Acute Lymphoblastic Leukemia (ALL) === | + | === Drugs Approved for Acute Lymphoblastic Leukemia (ALL) === <!--T:4--> |
| + | <!--T:5--> | ||
Arranon (Nelarabine) | Arranon (Nelarabine) | ||
| + | <!--T:6--> | ||
Asparaginase Erwinia chrysanthemi | Asparaginase Erwinia chrysanthemi | ||
| + | <!--T:7--> | ||
Asparlas (Calaspargase Pegol-mknl) | Asparlas (Calaspargase Pegol-mknl) | ||
| + | <!--T:8--> | ||
Besponsa (Inotuzumab Ozogamicin) | Besponsa (Inotuzumab Ozogamicin) | ||
| + | <!--T:9--> | ||
Blinatumomab | Blinatumomab | ||
| + | <!--T:10--> | ||
Blincyto (Blinatumomab) | Blincyto (Blinatumomab) | ||
| + | <!--T:11--> | ||
Calaspargase Pegol-mknl | Calaspargase Pegol-mknl | ||
| + | <!--T:12--> | ||
Cerubidine (Daunorubicin Hydrochloride) | Cerubidine (Daunorubicin Hydrochloride) | ||
| + | <!--T:13--> | ||
Clofarabine | Clofarabine | ||
| + | <!--T:14--> | ||
Clolar (Clofarabine) | Clolar (Clofarabine) | ||
| + | <!--T:15--> | ||
Cyclophosphamide | Cyclophosphamide | ||
| + | <!--T:16--> | ||
Cytarabine | Cytarabine | ||
| + | <!--T:17--> | ||
Dasatinib | Dasatinib | ||
| + | <!--T:18--> | ||
Daunorubicin Hydrochloride | Daunorubicin Hydrochloride | ||
| + | <!--T:19--> | ||
Dexamethasone | Dexamethasone | ||
| + | <!--T:20--> | ||
Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | ||
| + | <!--T:21--> | ||
Erwinaze (Asparaginase Erwinia Chrysanthemi) | Erwinaze (Asparaginase Erwinia Chrysanthemi) | ||
| + | <!--T:22--> | ||
Gleevec (Imatinib Mesylate) | Gleevec (Imatinib Mesylate) | ||
| + | <!--T:23--> | ||
Iclusig (Ponatinib Hydrochloride) | Iclusig (Ponatinib Hydrochloride) | ||
| + | <!--T:24--> | ||
Inotuzumab Ozogamicin | Inotuzumab Ozogamicin | ||
| + | <!--T:25--> | ||
Imatinib Mesylate | Imatinib Mesylate | ||
| + | <!--T:26--> | ||
Kymriah (Tisagenlecleucel) | Kymriah (Tisagenlecleucel) | ||
| + | <!--T:27--> | ||
Marqibo (Vincristine Sulfate Liposome) | Marqibo (Vincristine Sulfate Liposome) | ||
| + | <!--T:28--> | ||
Mercaptopurine | Mercaptopurine | ||
| + | <!--T:29--> | ||
Methotrexate | Methotrexate | ||
| + | <!--T:30--> | ||
Nelarabine | Nelarabine | ||
| + | <!--T:31--> | ||
Oncaspar (Pegaspargase) | Oncaspar (Pegaspargase) | ||
| + | <!--T:32--> | ||
Pegaspargase | Pegaspargase | ||
| + | <!--T:33--> | ||
Ponatinib Hydrochloride | Ponatinib Hydrochloride | ||
| + | <!--T:34--> | ||
Prednisone | Prednisone | ||
| + | <!--T:35--> | ||
Purinethol (Mercaptopurine) | Purinethol (Mercaptopurine) | ||
| + | <!--T:36--> | ||
Purixan (Mercaptopurine) | Purixan (Mercaptopurine) | ||
| + | <!--T:37--> | ||
Rubidomycin (Daunorubicin Hydrochloride) | Rubidomycin (Daunorubicin Hydrochloride) | ||
| + | <!--T:38--> | ||
Sprycel (Dasatinib) | Sprycel (Dasatinib) | ||
| + | <!--T:39--> | ||
Tisagenlecleucel | Tisagenlecleucel | ||
| + | <!--T:40--> | ||
Trexall (Methotrexate) | Trexall (Methotrexate) | ||
| + | <!--T:41--> | ||
Vincristine Sulfate | Vincristine Sulfate | ||
| + | <!--T:42--> | ||
Vincristine Sulfate Liposome | Vincristine Sulfate Liposome | ||
| − | === Drug Combinations Used in Acute Lymphoblastic Leukemia (ALL) === | + | === Drug Combinations Used in Acute Lymphoblastic Leukemia (ALL) === <!--T:43--> |
| + | <!--T:44--> | ||
Hyper-CVAD | Hyper-CVAD | ||
| − | === Drugs Approved for Acute Myeloid Leukemia (AML) === | + | === Drugs Approved for Acute Myeloid Leukemia (AML) === <!--T:45--> |
| + | <!--T:46--> | ||
Arsenic Trioxide | Arsenic Trioxide | ||
| + | <!--T:47--> | ||
Cerubidine (Daunorubicin Hydrochloride) | Cerubidine (Daunorubicin Hydrochloride) | ||
| + | <!--T:48--> | ||
Cyclophosphamide | Cyclophosphamide | ||
| + | <!--T:49--> | ||
Cytarabine | Cytarabine | ||
| + | <!--T:50--> | ||
Daunorubicin Hydrochloride | Daunorubicin Hydrochloride | ||
| + | <!--T:51--> | ||
Daunorubicin Hydrochloride and Cytarabine Liposome | Daunorubicin Hydrochloride and Cytarabine Liposome | ||
| + | <!--T:52--> | ||
Daurismo (Glasdegib Maleate) | Daurismo (Glasdegib Maleate) | ||
| + | <!--T:53--> | ||
Dexamethasone | Dexamethasone | ||
| + | <!--T:54--> | ||
Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | ||
| + | <!--T:55--> | ||
Enasidenib Mesylate | Enasidenib Mesylate | ||
| + | <!--T:56--> | ||
Gemtuzumab Ozogamicin | Gemtuzumab Ozogamicin | ||
| + | <!--T:57--> | ||
Gilteritinib Fumarate | Gilteritinib Fumarate | ||
| + | <!--T:58--> | ||
Glasdegib Maleate | Glasdegib Maleate | ||
| + | <!--T:59--> | ||
Idamycin PFS (Idarubicin Hydrochloride) | Idamycin PFS (Idarubicin Hydrochloride) | ||
| + | <!--T:60--> | ||
Idarubicin Hydrochloride | Idarubicin Hydrochloride | ||
| + | <!--T:61--> | ||
Idhifa (Enasidenib Mesylate) | Idhifa (Enasidenib Mesylate) | ||
| + | <!--T:62--> | ||
Ivosidenib | Ivosidenib | ||
| + | <!--T:63--> | ||
Midostaurin | Midostaurin | ||
| + | <!--T:64--> | ||
Mitoxantrone Hydrochloride | Mitoxantrone Hydrochloride | ||
| + | <!--T:65--> | ||
Mylotarg (Gemtuzumab Ozogamicin) | Mylotarg (Gemtuzumab Ozogamicin) | ||
| + | <!--T:66--> | ||
Rubidomycin (Daunorubicin Hydrochloride) | Rubidomycin (Daunorubicin Hydrochloride) | ||
| + | <!--T:67--> | ||
Rydapt (Midostaurin) | Rydapt (Midostaurin) | ||
| + | <!--T:68--> | ||
Tabloid (Thioguanine) | Tabloid (Thioguanine) | ||
| + | <!--T:69--> | ||
Thioguanine | Thioguanine | ||
| + | <!--T:70--> | ||
Tibsovo (Ivosidenib) | Tibsovo (Ivosidenib) | ||
| + | <!--T:71--> | ||
Trisenox (Arsenic Trioxide) | Trisenox (Arsenic Trioxide) | ||
| + | <!--T:72--> | ||
Venclexta (Venetoclax) | Venclexta (Venetoclax) | ||
| + | <!--T:73--> | ||
Venetoclax | Venetoclax | ||
| + | <!--T:74--> | ||
Vincristine Sulfate | Vincristine Sulfate | ||
| + | <!--T:75--> | ||
Vyxeos (Daunorubicin Hydrochloride and Cytarabine Liposome) | Vyxeos (Daunorubicin Hydrochloride and Cytarabine Liposome) | ||
| + | <!--T:76--> | ||
Xospata (Gilteritinib Fumarate) | Xospata (Gilteritinib Fumarate) | ||
| − | === Drug Combinations Used in Acute Myeloid Leukemia (AML) === | + | === Drug Combinations Used in Acute Myeloid Leukemia (AML) === <!--T:77--> |
| + | <!--T:78--> | ||
ADE | ADE | ||
| − | === Drugs Approved for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) === | + | === Drugs Approved for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) === <!--T:79--> |
| + | <!--T:80--> | ||
*Elzonris (Tagraxofusp-erzs) | *Elzonris (Tagraxofusp-erzs) | ||
| + | <!--T:81--> | ||
*Tagraxofusp-erzs | *Tagraxofusp-erzs | ||
| − | === Drugs Approved for Chronic Lymphocytic Leukemia (CLL) === | + | === Drugs Approved for Chronic Lymphocytic Leukemia (CLL) === <!--T:82--> |
| + | <!--T:83--> | ||
Alemtuzumab | Alemtuzumab | ||
| + | <!--T:84--> | ||
Arzerra (Ofatumumab) | Arzerra (Ofatumumab) | ||
| + | <!--T:85--> | ||
Bendamustine Hydrochloride | Bendamustine Hydrochloride | ||
| + | <!--T:86--> | ||
Bendeka (Bendamustine Hydrochloride) | Bendeka (Bendamustine Hydrochloride) | ||
| + | <!--T:87--> | ||
Campath (Alemtuzumab) | Campath (Alemtuzumab) | ||
| + | <!--T:88--> | ||
Chlorambucil | Chlorambucil | ||
| + | <!--T:89--> | ||
Copiktra (Duvelisib) | Copiktra (Duvelisib) | ||
| + | <!--T:90--> | ||
Cyclophosphamide | Cyclophosphamide | ||
| + | <!--T:91--> | ||
Dexamethasone | Dexamethasone | ||
| + | <!--T:92--> | ||
Duvelisib | Duvelisib | ||
| + | <!--T:93--> | ||
Fludarabine Phosphate | Fludarabine Phosphate | ||
| + | <!--T:94--> | ||
Gazyva (Obinutuzumab) | Gazyva (Obinutuzumab) | ||
| + | <!--T:95--> | ||
Ibrutinib | Ibrutinib | ||
| + | <!--T:96--> | ||
Idelalisib | Idelalisib | ||
| + | <!--T:97--> | ||
Imbruvica (Ibrutinib) | Imbruvica (Ibrutinib) | ||
| + | <!--T:98--> | ||
Leukeran (Chlorambucil) | Leukeran (Chlorambucil) | ||
| + | <!--T:99--> | ||
Mechlorethamine Hydrochloride | Mechlorethamine Hydrochloride | ||
| + | <!--T:100--> | ||
Mustargen (Mechlorethamine Hydrochloride) | Mustargen (Mechlorethamine Hydrochloride) | ||
| + | <!--T:101--> | ||
Obinutuzumab | Obinutuzumab | ||
| + | <!--T:102--> | ||
Ofatumumab | Ofatumumab | ||
| + | <!--T:103--> | ||
Prednisone | Prednisone | ||
| + | <!--T:104--> | ||
Rituxan (Rituximab) | Rituxan (Rituximab) | ||
| + | <!--T:105--> | ||
Rituxan Hycela (Rituximab and Hyaluronidase Human) | Rituxan Hycela (Rituximab and Hyaluronidase Human) | ||
| + | <!--T:106--> | ||
Rituximab | Rituximab | ||
| + | <!--T:107--> | ||
Rituximab and Hyaluronidase Human | Rituximab and Hyaluronidase Human | ||
| + | <!--T:108--> | ||
Treanda (Bendamustine Hydrochloride) | Treanda (Bendamustine Hydrochloride) | ||
| + | <!--T:109--> | ||
Venclexta (Venetoclax) | Venclexta (Venetoclax) | ||
| + | <!--T:110--> | ||
Venetoclax | Venetoclax | ||
| + | <!--T:111--> | ||
Zydelig (Idelalisib) | Zydelig (Idelalisib) | ||
| − | === Drug Combinations Used in Chronic Lymphocytic Leukemia (CLL) === | + | === Drug Combinations Used in Chronic Lymphocytic Leukemia (CLL) === <!--T:112--> |
| + | <!--T:113--> | ||
CHLORAMBUCIL-PREDNISONE | CHLORAMBUCIL-PREDNISONE | ||
| + | <!--T:114--> | ||
CVP | CVP | ||
| − | === Drugs Approved for Chronic Myelogenous Leukemia (CML) === | + | === Drugs Approved for Chronic Myelogenous Leukemia (CML) === <!--T:115--> |
| + | <!--T:116--> | ||
Bosulif (Bosutinib) | Bosulif (Bosutinib) | ||
| + | <!--T:117--> | ||
Bosutinib | Bosutinib | ||
| + | <!--T:118--> | ||
Busulfan | Busulfan | ||
| + | <!--T:119--> | ||
Busulfex (Busulfan) | Busulfex (Busulfan) | ||
| + | <!--T:120--> | ||
Cyclophosphamide | Cyclophosphamide | ||
| + | <!--T:121--> | ||
Cytarabine | Cytarabine | ||
| + | <!--T:122--> | ||
Dasatinib | Dasatinib | ||
| + | <!--T:123--> | ||
Dexamethasone | Dexamethasone | ||
| + | <!--T:124--> | ||
Gleevec (Imatinib Mesylate) | Gleevec (Imatinib Mesylate) | ||
| + | <!--T:125--> | ||
Hydrea (Hydroxyurea) | Hydrea (Hydroxyurea) | ||
| + | <!--T:126--> | ||
Hydroxyurea | Hydroxyurea | ||
| + | <!--T:127--> | ||
Iclusig (Ponatinib Hydrochloride) | Iclusig (Ponatinib Hydrochloride) | ||
| + | <!--T:128--> | ||
Imatinib Mesylate | Imatinib Mesylate | ||
| + | <!--T:129--> | ||
Mechlorethamine Hydrochloride | Mechlorethamine Hydrochloride | ||
| + | <!--T:130--> | ||
Mustargen (Mechlorethamine Hydrochloride) | Mustargen (Mechlorethamine Hydrochloride) | ||
| + | <!--T:131--> | ||
Myleran (Busulfan) | Myleran (Busulfan) | ||
| + | <!--T:132--> | ||
Nilotinib | Nilotinib | ||
| + | <!--T:133--> | ||
Omacetaxine Mepesuccinate | Omacetaxine Mepesuccinate | ||
| + | <!--T:134--> | ||
Ponatinib Hydrochloride | Ponatinib Hydrochloride | ||
| + | <!--T:135--> | ||
Sprycel (Dasatinib) | Sprycel (Dasatinib) | ||
| + | <!--T:136--> | ||
Synribo (Omacetaxine Mepesuccinate) | Synribo (Omacetaxine Mepesuccinate) | ||
| + | <!--T:137--> | ||
Tasigna (Nilotinib) | Tasigna (Nilotinib) | ||
| + | <!--T:138--> | ||
Drugs Approved for Hairy Cell Leukemia | Drugs Approved for Hairy Cell Leukemia | ||
| + | <!--T:139--> | ||
Cladribine | Cladribine | ||
| + | <!--T:140--> | ||
Intron A (Recombinant Interferon Alfa-2b) | Intron A (Recombinant Interferon Alfa-2b) | ||
| + | <!--T:141--> | ||
Lumoxiti (Moxetumomab Pasudotox-tdfk) | Lumoxiti (Moxetumomab Pasudotox-tdfk) | ||
| + | <!--T:142--> | ||
Moxetumomab Pasudotox-tdfk | Moxetumomab Pasudotox-tdfk | ||
| + | <!--T:143--> | ||
Recombinant Interferon Alfa-2b | Recombinant Interferon Alfa-2b | ||
| − | === Drugs Approved for Mast Cell Leukemia === | + | === Drugs Approved for Mast Cell Leukemia === <!--T:144--> |
| + | <!--T:145--> | ||
Midostaurin | Midostaurin | ||
| + | <!--T:146--> | ||
Rydapt (Midostaurin) | Rydapt (Midostaurin) | ||
| − | === Drugs Approved for Meningeal Leukemia === | + | === Drugs Approved for Meningeal Leukemia === <!--T:147--> |
| + | <!--T:148--> | ||
Cytarabine | Cytarabine | ||
</translate> | </translate> | ||
Latest revision as of 21:33, 29 October 2019
Contents
- 1 Drugs Approved for Leukemia
- 1.1 Drugs Approved for Acute Lymphoblastic Leukemia (ALL)
- 1.2 Drug Combinations Used in Acute Lymphoblastic Leukemia (ALL)
- 1.3 Drugs Approved for Acute Myeloid Leukemia (AML)
- 1.4 Drug Combinations Used in Acute Myeloid Leukemia (AML)
- 1.5 Drugs Approved for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- 1.6 Drugs Approved for Chronic Lymphocytic Leukemia (CLL)
- 1.7 Drug Combinations Used in Chronic Lymphocytic Leukemia (CLL)
- 1.8 Drugs Approved for Chronic Myelogenous Leukemia (CML)
- 1.9 Drugs Approved for Mast Cell Leukemia
- 1.10 Drugs Approved for Meningeal Leukemia
Drugs Approved for Leukemia
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for leukemia. The list includes generic and brand names. This page also lists common drug combinations used in leukemia. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in leukemia that are not listed here.
Drugs Approved for Acute Lymphoblastic Leukemia (ALL)
Arranon (Nelarabine)
Asparaginase Erwinia chrysanthemi
Asparlas (Calaspargase Pegol-mknl)
Besponsa (Inotuzumab Ozogamicin)
Blinatumomab
Blincyto (Blinatumomab)
Calaspargase Pegol-mknl
Cerubidine (Daunorubicin Hydrochloride)
Clofarabine
Clolar (Clofarabine)
Cyclophosphamide
Cytarabine
Dasatinib
Daunorubicin Hydrochloride
Dexamethasone
Doxorubicin Hydrochloride
Erwinaze (Asparaginase Erwinia Chrysanthemi)
Gleevec (Imatinib Mesylate)
Iclusig (Ponatinib Hydrochloride)
Inotuzumab Ozogamicin
Imatinib Mesylate
Kymriah (Tisagenlecleucel)
Marqibo (Vincristine Sulfate Liposome)
Mercaptopurine
Methotrexate
Nelarabine
Oncaspar (Pegaspargase)
Pegaspargase
Ponatinib Hydrochloride
Prednisone
Purinethol (Mercaptopurine)
Purixan (Mercaptopurine)
Rubidomycin (Daunorubicin Hydrochloride)
Sprycel (Dasatinib)
Tisagenlecleucel
Trexall (Methotrexate)
Vincristine Sulfate
Vincristine Sulfate Liposome
Drug Combinations Used in Acute Lymphoblastic Leukemia (ALL)
Hyper-CVAD
Drugs Approved for Acute Myeloid Leukemia (AML)
Arsenic Trioxide
Cerubidine (Daunorubicin Hydrochloride)
Cyclophosphamide
Cytarabine
Daunorubicin Hydrochloride
Daunorubicin Hydrochloride and Cytarabine Liposome
Daurismo (Glasdegib Maleate)
Dexamethasone
Doxorubicin Hydrochloride
Enasidenib Mesylate
Gemtuzumab Ozogamicin
Gilteritinib Fumarate
Glasdegib Maleate
Idamycin PFS (Idarubicin Hydrochloride)
Idarubicin Hydrochloride
Idhifa (Enasidenib Mesylate)
Ivosidenib
Midostaurin
Mitoxantrone Hydrochloride
Mylotarg (Gemtuzumab Ozogamicin)
Rubidomycin (Daunorubicin Hydrochloride)
Rydapt (Midostaurin)
Tabloid (Thioguanine)
Thioguanine
Tibsovo (Ivosidenib)
Trisenox (Arsenic Trioxide)
Venclexta (Venetoclax)
Venetoclax
Vincristine Sulfate
Vyxeos (Daunorubicin Hydrochloride and Cytarabine Liposome)
Xospata (Gilteritinib Fumarate)
Drug Combinations Used in Acute Myeloid Leukemia (AML)
ADE
Drugs Approved for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Elzonris (Tagraxofusp-erzs)
- Tagraxofusp-erzs
Drugs Approved for Chronic Lymphocytic Leukemia (CLL)
Alemtuzumab
Arzerra (Ofatumumab)
Bendamustine Hydrochloride
Bendeka (Bendamustine Hydrochloride)
Campath (Alemtuzumab)
Chlorambucil
Copiktra (Duvelisib)
Cyclophosphamide
Dexamethasone
Duvelisib
Fludarabine Phosphate
Gazyva (Obinutuzumab)
Ibrutinib
Idelalisib
Imbruvica (Ibrutinib)
Leukeran (Chlorambucil)
Mechlorethamine Hydrochloride
Mustargen (Mechlorethamine Hydrochloride)
Obinutuzumab
Ofatumumab
Prednisone
Rituxan (Rituximab)
Rituxan Hycela (Rituximab and Hyaluronidase Human)
Rituximab
Rituximab and Hyaluronidase Human
Treanda (Bendamustine Hydrochloride)
Venclexta (Venetoclax)
Venetoclax
Zydelig (Idelalisib)
Drug Combinations Used in Chronic Lymphocytic Leukemia (CLL)
CHLORAMBUCIL-PREDNISONE
CVP
Drugs Approved for Chronic Myelogenous Leukemia (CML)
Bosulif (Bosutinib)
Bosutinib
Busulfan
Busulfex (Busulfan)
Cyclophosphamide
Cytarabine
Dasatinib
Dexamethasone
Gleevec (Imatinib Mesylate)
Hydrea (Hydroxyurea)
Hydroxyurea
Iclusig (Ponatinib Hydrochloride)
Imatinib Mesylate
Mechlorethamine Hydrochloride
Mustargen (Mechlorethamine Hydrochloride)
Myleran (Busulfan)
Nilotinib
Omacetaxine Mepesuccinate
Ponatinib Hydrochloride
Sprycel (Dasatinib)
Synribo (Omacetaxine Mepesuccinate)
Tasigna (Nilotinib)
Drugs Approved for Hairy Cell Leukemia
Cladribine
Intron A (Recombinant Interferon Alfa-2b)
Lumoxiti (Moxetumomab Pasudotox-tdfk)
Moxetumomab Pasudotox-tdfk
Recombinant Interferon Alfa-2b
Drugs Approved for Mast Cell Leukemia
Midostaurin
Rydapt (Midostaurin)
Drugs Approved for Meningeal Leukemia
Cytarabine
